Christopher & Banks Corporation
CBKCQ · OTC
10/31/2020 | 8/1/2020 | 5/2/2020 | 2/1/2020 | |
|---|---|---|---|---|
| Revenue | $72,797 | $58,481 | $40,125 | $88,126 |
| % Growth | 24.5% | 45.7% | -54.5% | – |
| Cost of Goods Sold | $54,862 | $52,101 | $36,401 | $61,313 |
| Gross Profit | $17,935 | $6,380 | $3,724 | $26,813 |
| % Margin | 24.6% | 10.9% | 9.3% | 30.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $29,921 |
| SG&A Expenses | $26,308 | $19,361 | $18,523 | $29,930 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $9 |
| Other Operating Expenses | $1,993 | $1,870 | $1,906 | $1,987 |
| Operating Expenses | $28,301 | $21,231 | $20,429 | $31,917 |
| Operating Income | -$10,366 | -$14,851 | -$16,705 | -$5,104 |
| % Margin | -14.2% | -25.4% | -41.6% | -5.8% |
| Other Income/Exp. Net | -$270 | -$280 | -$273 | -$70 |
| Pre-Tax Income | -$10,817 | -$15,131 | -$17,242 | -$5,174 |
| Tax Expense | -$9 | -$37 | -$4 | -$86 |
| Net Income | -$10,808 | -$15,094 | -$17,238 | -$5,088 |
| % Margin | -14.8% | -25.8% | -43% | -5.8% |
| EPS | -0.29 | -0.4 | -0.46 | -0.14 |
| % Growth | 27.5% | 13% | -228.6% | – |
| EPS Diluted | -0.29 | -0.4 | -0.46 | -0.14 |
| Weighted Avg Shares Out | 37,855 | 37,693 | 37,555 | 37,538 |
| Weighted Avg Shares Out Dil | 37,855 | 37,693 | 37,555 | 37,538 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $270 | $280 | $273 | $70 |
| Depreciation & Amortization | $1,993 | $1,870 | $1,906 | $1,987 |
| EBITDA | -$8,373 | -$12,981 | -$14,799 | -$3,117 |
| % Margin | -11.5% | -22.2% | -36.9% | -3.5% |